We need to talk about flower – the vexing challenge of dried cannabis by Steve Jones September 21, 2022April 29, 2024 As awareness of legal medical cannabis has increased, so too has demand for flower. In the […]
‘Being a start-up in a start-up industry is not easy. It’s been turbulent. But we’re ready to go.’ by Steve Jones August 29, 2022April 29, 2024
GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial by Steve Jones April 7, 2022April 29, 2024
Over-the-counter race hots up as Cann Group prepares to recruit patients for sleep disturbance trial by Steve Jones February 16, 2022April 29, 2024
A year of frustration but Cann Group vows to deliver for shareholders and consumers by Steve Jones August 12, 2021April 26, 2024
Cann Group ships delayed order of 20,000 bottles to German partner iuvo by Steve Jones May 6, 2021April 26, 2024
TGA boss tells industry: ‘future dosing limits are in your hands’ by Martin Lane March 16, 2021April 26, 2024
Cannatrek releases first home-grown flower as firms react to shortage by Steve Jones March 11, 2021April 26, 2024
Cann Group COO: ‘we need to put our big boy pants on and adopt a pharmaceutical mindset’ by Steve Jones February 25, 2021April 26, 2024
